肝脏恶性肿瘤682例手术治疗分析

目的　探讨影响肝脏恶性肿瘤患者手术治疗后长期生存的因素。方法　回顾性分析1989年 1月至 2 0 0 3年 1月施行外科手术治疗的 6 82例肝脏恶性肿瘤患者的临床资料。结果　小肝癌 (直径 <5cm ,n =2 96 )患者术后 3年、5年生存率分别为 (6 1 2 5± 4 4 1) %和 (5 3 84± 5 6 8) % ,巨大肝癌 (直径 >10cm ,n =14 5 )患者术后 3年、5年生存率分别为 (45 90± 6 98) %和 (30 2 1±10 2 3) % ;肿瘤单发患者 (n =4 0 3)术后 3年、5年生存率分别为 (6 1 86± 3 6 9) %和 (5 5 4 0±4 91) % ,肿瘤多发 (2个或 2个以上 )患者 (n =2 4 6 )术后 3年、5年生存率分别为 (38 31± 4 97) %和(2 8 0 1± 6 31) % ;术前肝功能Child分期为Ⅰ期的患者 (n =397)术后 3年、5年生存率分别为 (6 0 6 8± 3 6 8) %和 (5 0 99± 5 10 ) % ,Ⅱ期或Ⅱ期以上的患者 (n =2 85 )术后 3年、5年生存率则为 (43 0 1±5 33) %和 (36 39± 7 5 8) % ;行局部或一段切除的患者 (n =2 98)术后 3年、5年生存率分别为 (6 8 6 5± 4 95 ) %和 (6 5 38± 5 6 9) % ,行两段或两段以上及半肝切除的患者 (n =32 4 )术后 3年、5年生存率分别为 (49 88± 4 13) %和 (37 98± 5 70 ) %。结论　小肝癌

Retrospective analysis on 682 cases of liver cancer after surgical treatment

OBJECTIVE: To investigate the factors of long-turn survival of liver cancer after surgical treatment. METHODS: Five hundred and twenty-two cases of liver cancer that received surgical treatment in 14 years were analyzed retrospectively. RESULTS: Comparison between the small liver cancer (< 5 cm) and the greater one (> 10 cm) revealed that the small liver cancer had a higher survival rates than the greater one [3 year (61.25 +/- 4.41)% versus (45.90 +/- 6.98)%; 5 year (53.84 +/- 5.68)% versus (30.21 +/- 10.23)%]. There were same results between single-nodule and two or more than two nodule [3 year (61.86 +/- 3.69)% versus (38.31 +/- 4.97)%; 5 year (55.40 +/- 4.91)% versus (28.01 +/- 6.31)%], between child I and child II or more than II [3 year (60.68 +/- 3.68)% versus (49.88 +/- 4.13)%; 5 year (50.99 +/- 5.10)% versus (36.39 +/- 7.58)%], and between single segmentectomy of the liver and two or more than two segmentectomy [3 year (68.65 +/- 4.95)% versus (49.88 +/- 4.13)%; 5 year (65.38 +/- 5.69)% versus (37.98 +/- 5.70)%]. CONCLUSIONS: Small liver cancer, single-nodule, good hepatic function and minor resection were important factors to prolong survival further.